In recent years, health research has been undergoing two major, yet seemingly opposing, shifts: a deep dive into individual-centric medicine and a broadened focus on population-wide studies. On the individual level, advancements in genomics are driving the shift toward personalized medicine, where
A groundbreaking gene therapy showing promise in preventing premature births and treating placental growth insufficiency holds the potential to significantly improve pregnancies worldwide. This revolutionary therapy is being developed by a dedicated team led by Dr. Helen N. Jones from the
The impact of glyphosate exposure on brain health has been a growing concern, and a new study has brought this issue to the forefront. The research highlights the potential link between the widely used herbicide and lasting brain inflammation, which could lead to neurodegenerative diseases such as
In a strategic move to tackle severe blood cancers, Alanis Therapeutics (ATI) has teamed up with KBI Biopharma to enhance the development and manufacturing of ATI's preclinical antibody candidate, ATI-D1. This partnership aims to accelerate the treatment of myelodysplastic syndromes (MDS) and acute
Imagine undergoing a medical procedure to remove kidney stones only to face discomfort because of a stent placed to prevent complications. Each year, thousands of patients undergo ureteroscopy to remove kidney stones, and while the procedure is effective, the placement of ureteral stents
Recent advancements in synthetic biology have opened new avenues for addressing antimicrobial resistance (AMR), a pressing global health threat. Synthetic biology encompasses the design and engineering of new or modified living systems to combat drug-resistant bacteria effectively. This field
Cancer treatment has long been challenged by the complexity of tumors that are composed of diverse populations of cancer cells, each reacting differently to treatments. This diversity not only complicates the development of effective treatments but also renders identifying the specific cells
The integration of Artificial Intelligence (AI) in healthcare holds immense potential to revolutionize patient care, clinical decision-making, and operational efficiency. However, realizing this potential requires a structured and responsible approach to ensure safety, equity, and effectiveness.
Beckman Coulter Life Sciences, a subsidiary of Danaher Corporation, has announced the launch of the Cydem VT Automated Clone Screening System, an innovative platform designed to transform the world of drug discovery through advanced laboratory automation and innovation. This groundbreaking
Platelets play an essential role in human physiology, particularly during the clotting process in response to injury. Despite their importance, the comprehension and measurement of platelet functionality have consistently posed challenges for scientists and clinicians. This issue has become even
